Deepak Fertilisers & Petrochemicals Corp Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 12 Jun 2026 | Chemicals & Petrochemicals | Market Cap: ₹20.1K Cr

Strong revenue growth was delivered despite a challenging environment (Page 6). Company expects progressively stronger performance driven by: - Tightening global supply conditions improving spreads.

From Deepak Fertilisers & Petrochemicals Corp Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

₹1,449

Market Cap

₹20.1K Cr

P/E Ratio

20.4

How does Deepak Fertilisers & Petrochemicals Corp Ltd rank in Chemicals & Petrochemicals?

Compare Deepak Fertilisers & Petrochemicals Corp Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Deepak Fertilisers & Petrochemicals Corp Ltd — Quarterly revenue & net profit

Revenue Net Profit

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.8K Cr, net profit ₹141 Cr.

Full financials →

📊 Revenue & Sales Performance

→Strong revenue growth was delivered despite a challenging environment (Page 6).
→Specialty products and B2C segments are key drivers, with increased contribution improving realization and customer engagement (Page 6).
→Ramp-up of new capacities (Gopalpur TAN project and Dahej nitric acid project) expected to provide further growth and operating leverage (Page 6).
→TAN volume growth driven by demand strengthening, especially in the last quarter; new Gopalpur facility to increase volume further (Pages 7-8).
→Specialty chemical segment focused on introducing new products, in-sourcing from JV partners, and deeper market penetration to achieve higher growth and margin uplift (Page 16).
→Market-aligned flexible production enables responding to shifting demand for product mixes (Page 9).
→Overall outlook confident for progressively stronger performance with improved spreads and business mix (Page 6).

📈 Profitability & Margins

→Company expects progressively stronger performance driven by:
→ - Tightening global supply conditions improving spreads.
→ - Better cost visibility and stability from long-term gas arrangement (15-year LNG contract with Equinor).
→ - Stronger business mix with higher contribution from Specialty products and B2C segment.
→Ramp-up of new capacities at Gopalpur TAN project and Dahej nitric acid project (expected commissioning in Q2 FY '27) to support growth and operating leverage.
→Specialty Chemicals and Crop Nutrition segments to see growth due to new product introductions, deeper market penetration, and improved product mix.
→Margin uplift expected as Specialty segment's share increases, given higher margin profile compared to subsidized fertilizer business.
→Early signs of recovery seen in Industrial Chemicals segment with improving spreads and tighter supply.
→Overall, expectation of improved earnings, operating profits, and EPS in medium term supported by these levers and capacity expansions.

🏗️ Capital Expenditure Plans

→Ongoing key growth projects: Gopalpur TAN project (~95% complete) and Dahej nitric acid project (~86% complete).
→Total project capex: Around INR4,650 crores; cumulative spend including GST and advances ~INR3,800 crores.
→Capex for FY'27 expected to be elevated at INR800-1,000 crores (including maintenance), reflecting completion phase of current projects.
→Post FY'27, capex expected to normalize as current investment cycle concludes.
→New plants will be added at recently acquired Chardham Chemicals facility to capitalize on licensed capacity.
→Strategic acquisition of an explosive unit to enhance mining chemical platform and deliver integrated value-added solutions.
→Plans to upgrade newly acquired facilities to Deepak standards with focus on extensive product portfolio and market reach.
→Focus on growing specialty fertiliser business through R&D and JV partnerships for product innovation and geographical expansion.

💰 Fundraising & Capital Structure

→There is no explicit mention of any current or immediate future fundraising through debt or equity in the transcript.
→The company has already undergone significant capex (~INR4,650 crores) for key growth projects, with around INR3,800 crores spent, indicating they are in the final investment phase.
→Net debt stands at INR4,824 crores with a net debt to EBITDA ratio of 2.86x, reflecting the end of the investment cycle.
→Management did not indicate any upcoming equity or debt issuance during the call.
→They mentioned plans for possible subsidiary listing or demerger but have not finalized form, shape, or timing, suggesting no immediate equity funding in this regard.
→The company is focusing on project completion and operational ramp-up rather than fresh fundraising at this time.

📋 Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Deepak Fertilisers and Petrochemicals Corporation Limited. However, some relevant insights related to business outlook are: - Specialty Chemicals business focus: Growing specialty fertiliser products with deeper geographical penetration to increase revenue share and margins. - Acquisition Activities: Acquired Chardham Chemicals; plans to upgrade and revamp facilities to start revenue flow, but no large capex expected. - TAN (Ammonium Nitrate) Business: Demand strengthening in Q4 driven by mineral production targets; volumes expected to increase post-Gopalpur plant commissioning. - Ammonia Supply: Multiple contracts to ensure continuous supply; no supply disruptions expected. - New Projects: Some delays due to workforce shortage but progressing well. No direct data on order book value or specific pending orders was disclosed in the available transcript.

Key Metrics

What Deepak Fertilis.'s management said in earlier quarters

Others in Chemicals & Petrochemicals this season

NOCIL (Q4 FY26)
The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…
Indo Borax & Chemicals Ltd (Q4 FY26)
175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…
Rossari Biotech (Q4 FY26)
50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…
Pidilite Inds. (Q4 FY26)
Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…

Compare:vs Solar Industries India Ltd vs Pidilite Inds.vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Deepak Fertilisers & Petrochemicals Corp Ltd Q4 FY26 results?

Strong revenue growth was delivered despite a challenging environment (Page 6). Company expects progressively stronger performance driven by: - Tightening global supply conditions improving spreads.

What is Deepak Fertilisers & Petrochemicals Corp Ltd share price analysis?

Deepak Fertilisers & Petrochemicals Corp Ltd currently shows a neutral. The stock trades at a P/E of 20.4 with a market cap of ₹20,127 Cr. Investors should review the full earnings analysis for detailed insights.

Is Deepak Fertilisers & Petrochemicals Corp Ltd planning capital expenditure?

Ongoing key growth projects: Gopalpur TAN project (~95% complete) and Dahej nitric acid project (~86% complete).

Keep Deepak Fertilisers & Petrochemicals Corp Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.